Molecular Mechanisms and Innovative Therapies for Advancing Cancer Treatment

A comprehensive understanding of the molecular and cellular basis of cancer is essential for driving forward innovations in treatment and improving patient outcomes. Recent years have witnessed remarkable advances in delineating the complex biological processes that initiate and sustain cancer, govern its progression, and shape responses to therapy. However, key challenges—including tumor heterogeneity, metastasis, and drug resistance—continue to impede the quest for lasting, curative interventions.

This Research Topic aims to provide a platform for the latest research and insightful reviews addressing the multifaceted mechanisms at play in cancer biology. We welcome submissions that explore, but are not limited to:

o Genetic and epigenetic alterations governing tumor initiation and evolution

o Regulation of cell signalling pathways and their impact on growth, survival, and immune evasion

o Interaction between cancer cells and the tumor microenvironment, including stromal and immune components

o Mechanisms of metastasis and the factors influencing cancer dissemination

o Molecular determinants of therapeutic response and resistance

o Development of novel targeted therapies, immunotherapies, and combination treatments

o Innovative approaches for overcoming drug resistance and enhancing therapeutic durability

o Translational strategies aimed at integrating mechanistic discoveries into clinical practice

By gathering original research articles, reviews, and perspectives, this Research Topic seeks to highlight recent breakthroughs that bridge basic molecular insights and clinical applications. Our goal is to foster discussion and collaboration across disciplines, ultimately paving the way toward more effective, durable, and patient-centered cancer care.

We look forward to your contributions that will advance our understanding of cancer and inspire the development of next-generation therapies.




Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.

Keywords: Cancer Biology, Molecular Mechanisms, Tumor Microenvironment, Therapeutic Resistance, Targeted Therapies, Translational Oncology

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.